Acetyl-DL-leucine improves gait variability in patients with cerebellar ataxia—a case series

Acetyl-DL-leucine is a modified amino acid that was observed to improve ataxic symptoms in patients with sporadic and hereditary forms of ataxia. Here, we investigated the effect of the treatment with Acetyl-DL-leucine on the walking stability of patients with cerebellar ataxia (10x SAOA, 2x MSA-C,...

Descripción completa

Detalles Bibliográficos
Autores principales: Schniepp, Roman, Strupp, Michael, Wuehr, Max, Jahn, Klaus, Dieterich, Marianne, Brandt, Thomas, Feil, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828858/
https://www.ncbi.nlm.nih.gov/pubmed/27073690
http://dx.doi.org/10.1186/s40673-016-0046-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828858/
https://www.ncbi.nlm.nih.gov/pubmed/27073690
http://dx.doi.org/10.1186/s40673-016-0046-2

Ejemplares similares